Detalhe da pesquisa
1.
Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer.
Cancer Immunol Immunother
; 67(11): 1753-1765, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30167862
2.
Targeting of Aberrant αvß6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.
Mol Ther
; 25(1): 259-273, 2017 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28129120
3.
The integrin αvß6: a novel target for CAR T-cell immunotherapy?
Biochem Soc Trans
; 44(2): 349-55, 2016 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27068939
4.
Adoptive immunotherapy of epithelial ovarian cancer with Vγ9Vδ2 T cells, potentiated by liposomal alendronic acid.
J Immunol
; 193(11): 5557-66, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25339667
5.
Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity?
J Immunol
; 191(9): 4589-98, 2013 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24062490
6.
Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with Carboplatin.
J Immunol
; 191(5): 2437-45, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23898037
7.
Vaccinia virus induces programmed necrosis in ovarian cancer cells.
Mol Ther
; 21(11): 2074-86, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23985697
8.
Engineering a Dual Specificity γδ T-Cell Receptor for Cancer Immunotherapy.
Biology (Basel)
; 13(3)2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38534465
9.
Targeting of Aberrant αvß6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.
Mol Ther
; 25(10): 2427, 2017 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28958577
10.
Generation and application of TGFß-educated human Vγ9Vδ2 T cells.
STAR Protoc
; 3(2): 101319, 2022 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35496793
11.
Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptors.
Cell Rep Med
; 2(12): 100457, 2021 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35028604
12.
TGF-ß1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancer.
Cell Rep Med
; 2(12): 100473, 2021 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35028614
13.
Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth.
Front Immunol
; 11: 628776, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33365036
14.
CAR T-Cells Targeting the Integrin αvß6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies.
Cancers (Basel)
; 11(5)2019 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31091832
15.
CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth.
Front Immunol
; 10: 1149, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31178870
16.
Clinical Use of Programmed Cell Death-1 and Its Ligand Expression as Discriminatory and Predictive Markers in Ovarian Cancer.
Clin Cancer Res
; 23(13): 3453-3460, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27986748
17.
CAR T-cell immunotherapy of MET-expressing malignant mesothelioma.
Oncoimmunology
; 6(12): e1363137, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29209570
18.
CAR T-cell immunotherapy: The path from the by-road to the freeway?
Mol Oncol
; 9(10): 1994-2018, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26563646
19.
ErbB-targeted CAR T-cell immunotherapy of cancer.
Immunotherapy
; 7(3): 229-41, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25804476
20.
Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killing.
Adv Healthc Mater
; 4(8): 1180-9, 2015 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25866054